PIPELINE

0
INDICATIONS

OUR FOCUS

We focus on the development of repurposed small molecule drugs targeting neurological indications facilitated by our unique, behaviour based zebrafish screening technology.

ID Modality Reg. pathway Preclinical Phase I Phase II Phase III
3Z-20-001 α2/I1 agonist US NDA
EU 2001/83/EC 8(3)/10
Zebrafish POC ✓
Rodent POC ✓
3Z-20-002 α1 agonist US 505(b)(2)
EU 2001/83/EC 8(3)/10
Zebrafish POC ✓
3Z-20-003 L-type Ca blocker US 505(b)(2)
EU 2001/83/EC 8(3)/10
Zebrafish POC ✓
Rodent POC ✓
In silico ✓
3Z-20-004 NSAID US NDA
EU 2001/83/EC 8(3)/10
Zebrafish POC ✓
3Z-20-005 I1 agonist NDA Zebrafish POC ✓